Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.
about
Is increased antidepressant exposure a contributory factor to the obesity pandemic?Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersThe Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis.Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.Insulin resistance, diabetes mellitus, and brain structure in bipolar disordersPioglitazone could induce remission in major depression: a meta-analysisDepression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitusCardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.Obesity as an Early Symptom of the AMIS SyndromeEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysisEffects of a Social Welfare Program for Health Promotion on Cardiovascular Risk FactorsExercise therapy improves aerobic capacity of inpatients with major depressive disorder.Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder.Metabolic syndrome and central obesity in depression: A cross-sectional study.BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE.Diabetes mellitus and severe mental illness: mechanisms and clinical implications.TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS.Positive association between serious psychiatric outcomes and complications of diabetes mellitus in patients with depressive disorders.The association between adolescent psychopathology and subsequent physical activity in young adulthood: a 21-year birth cohort study.New way of working: Professionals' expectations and experiences of the Culture and Health Project for clients with psychiatric disabilities: A focus group study.Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study.Depression and risk of type 2 diabetes: the potential role of metabolic factors.Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.Plasma lipidomics reveals potential lipid markers of major depressive disorder.Prevalence and risk factors of moderate to severe obstructive sleep apnea syndrome in major depression: a observational and retrospective study on 703 subjects.Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly.Effects of an exercise program on the physiological, biological and psychological profiles in patients with mood disorders: a pilot study.Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.Metabolic syndrome in first-time hospitalized patients with depression: a 1-year follow-up study.Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.Lessons Learned From the Trial of a Cardiometabolic Health Nurse.Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study.Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS).Epigenetics of Metabolic Syndrome as a Mood Disorder.Improving access to specialized care for first-episode psychosis: an ecological modelMonitoring of somatic parameters at outpatient departments for mood and anxiety disorders
P2860
Q26765430-198D36EA-8535-4B17-B425-58E4DFB67611Q26782993-442B83AA-834B-4754-8F6F-D028343B1A30Q26797416-36C2060A-EB4C-4B4F-8B1E-29BF96B29BC7Q27023402-BF385D93-96D3-40FC-8262-ECCAF6732F44Q30249403-4C1654CD-CD78-437A-96E0-AC4931E5343DQ33670588-5D5A38DD-F69E-47BD-BCDF-7DC53BF4EC0CQ34357070-AEEB507E-2FDE-4897-BF4A-7DC2B40B7504Q34548227-6E1439AD-7500-4C4D-9E91-A688A6B13889Q35024642-24776D2E-3552-4872-9F39-6D8FFE1E6BFBQ35087495-B3745F3C-B16E-4687-9D6E-77D98AD1F763Q35750536-B635E179-4C70-47BF-ADA7-950AA28C8063Q35754726-F4C905FD-731E-4941-A941-56576477DE6DQ36118736-D60781ED-39B9-464B-935C-B58475BA0FC4Q36459728-A7C38BAB-C111-4D5D-B730-7146984D9B1DQ36830074-4A368C88-C3B6-4634-8D4D-8B15D574E199Q37397705-78FA200C-4FF7-411B-8E57-2817750221BBQ37400542-D83F20F0-85DF-428B-9F24-3FFBE5B4A611Q37418039-13E6A6AC-3DD9-4DE8-BD10-321B6E3AE6F3Q38274901-E66384D1-E5F2-4BC3-93A5-0962670E1572Q38538401-5407CBBD-D11E-47B5-B7EE-395BC4A17309Q38583648-A128DFF6-D366-4BE3-BA9C-F2FB442B1270Q38720693-86E563BA-7B7A-439D-A913-E66BB13479BDQ38752142-E442BFC2-256F-4F82-8E23-8AE66D802741Q39077270-93C3498D-F519-4ECE-B99C-CEA6C23D9390Q39504880-E25C2938-5605-4240-B478-ED58154CE453Q40894639-C73E290F-DA10-4408-9F7B-3D5E8E3839F5Q43233636-FAC1BA14-1F93-4DF5-B0C4-4CC5911D4EEDQ46511372-498B345A-550F-4975-B0F9-0D2E5B986883Q47153309-116753D4-C399-4BCD-8CCF-456387AA5DC4Q47623310-1BD09203-D6DB-4A03-920E-9B25DA873EC4Q47644943-50379385-5F6B-4DB4-9005-44EC2CC173A4Q47877921-D0E52953-1232-45F4-A6DD-2DCAA3DE9D99Q48076370-F64ADC14-4CB2-4595-8E0F-438D6577897BQ50075636-697E558B-5560-4FCA-94A5-86E3D782583BQ50617192-79680A7F-39D9-4DAE-B42E-F6C7209DE0A3Q53827450-4D458FEF-4DC0-4002-B7EA-2401D11526C8Q55186253-2AEB0C55-AAAD-4BA9-9562-DBF84E93BDA1Q55273449-5C473182-5E89-464A-A3A8-28CE2868BD2CQ57166809-ED20E702-E5AF-476B-80C3-8E89DF04FC0BQ58731395-E22DDE24-72C2-4C79-88B5-F277E02A7AA5
P2860
Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Metabolic syndrome and metabol ...... nces and moderating variables.
@ast
Metabolic syndrome and metabol ...... nces and moderating variables.
@en
Metabolic syndrome and metabol ...... nces and moderating variables.
@nl
type
label
Metabolic syndrome and metabol ...... nces and moderating variables.
@ast
Metabolic syndrome and metabol ...... nces and moderating variables.
@en
Metabolic syndrome and metabol ...... nces and moderating variables.
@nl
prefLabel
Metabolic syndrome and metabol ...... nces and moderating variables.
@ast
Metabolic syndrome and metabol ...... nces and moderating variables.
@en
Metabolic syndrome and metabol ...... nces and moderating variables.
@nl
P2093
P2860
P921
P1476
Metabolic syndrome and metabol ...... ences and moderating variables
@en
P2093
A De Herdt
C U Correll
D Vancampfort
T W Scheewe
P2860
P304
P356
10.1017/S0033291713002778
P407
P577
2013-11-21T00:00:00Z